Cita APA

Perez, R. E., Calhoun, S., Shim, D., Levenson, V. V., Duan, L., & Maki, C. G. (2020). Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther.

Chicago Style Citation

Perez, Ricardo E., Sarah Calhoun, Daeun Shim, Victor V. Levenson, Lei Duan, i Carl G. Maki. "Prolyl Endopeptidase Inhibitor Y-29794 Blocks the IRS1-AKT-mTORC1 Pathway and Inhibits Survival and in Vivo Tumor Growth of Triple-negative Breast Cancer." Cancer Biol Ther 2020.

Cita MLA

Perez, Ricardo E., et al. "Prolyl Endopeptidase Inhibitor Y-29794 Blocks the IRS1-AKT-mTORC1 Pathway and Inhibits Survival and in Vivo Tumor Growth of Triple-negative Breast Cancer." Cancer Biol Ther 2020.